openPR Logo
Press release

The HUB explores 3D organoid cultures for personalised modelling in drug discovery

11-17-2016 07:17 PM CET | Health & Medicine

Press release from: SMi Group

The HUB explores 3D organoid cultures for personalised

Robert Vries, Managing Director at the Hubrecht Organoid Technology Foundation (The HUB) has joined the speaker lineup for SMi Group’s launch conference on 3D Cell Culture. The event will take place on the 22nd and 23rd of February 2017 in London.

The HUB is a leading institution on organoid technology, and has established a ‘living biobank’. This growing collection of organoids from patients with various forms of cancer is used to link genetic and transcriptional information to drug responsiveness on a personal level. The HUB explores novel therapeutic strategies, including responsiveness to drug combinations, to develop rules for patient stratification based on drug responsiveness in vitro. This work is pivotal is progressing towards personalised treatments.

Against this backdrop, Robert will present a keynote entitled “3D organoid cultures: a personalised model in drug discovery as well as companion diagnostics” which addresses the following issues:
• how increasing the use of patient-derived cultures in preclinical development has the potential to identify, and eliminate, drugs likely to fail in preclinical trials;
• why high failure rates remains one of the greatest challenges to pharmaceutical drug development;
• how to use 3D and organoid biobanks to develop preclinical drug development tools and clinical personalised diagnostics; and
• how the use of organoid models has already led to successful patient specific treatments of Cystic Fibrosis

Robert joins a panel of experts from leading companies at the forefront of 3D Cell Culture innovation including AstraZeneca, Novartis, Lonza, GSK, TissUse, GE Healthcare Life Sciences, Epithelix, Microduits and more.

3D Cell Culture 2017 will address current challenges and emerging applications of this pivotal new technique by showcasing how 3D cell culture has revolutionised drug discovery and toxicity screening, as well as how it is emerging as an invaluable tool in stem-cell research and regenerative medicine.

For more details about the conference and registration information, visit

3D Cell Culture
22 & 23 February 2017
Copthorne Tara Hotel, London, UK

---end ---

Contact Information:
For sponsorship and exhibition queries please contact Alia Malick at For delegate queries please contact Matthew Apps at For media queries please contact Honey de Gracia at

About SMi Group:

Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at

1 Westminster Bridge Road SE1 7XW

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release The HUB explores 3D organoid cultures for personalised modelling in drug discovery here

News-ID: 383972 • Views: 410

More Releases from SMi Group

Exclusive Speaker Interview with AOBiome ahead of the 22nd Pain Therapeutics Con …
SMi Reports: Exclusive speaker interview with Todd Krueger at AOBiome released for the Pain Therapeutics Conference The pain therapeutics industry has grown at an exponential rate in recent years. The 22nd Annual Pain Therapeutics conference will cover the leading advances in pain therapeutics, exploring late development clinical trials, novel treatments for chronic conditions, technology collaboration treatments, using VR and Medical Devices that carry out non-invasive nerve stimulation. Industry leaders will uncover the
Exclusive Speaker Interview with Ester Lovsin Barle ahead of the 6th Annual High …
Now in its 6th year, the Highly Potent Active Pharmaceutical Ingredients conference offers you peer-to-peer networking with industry experts including heads and directors of EHS, Occupational Hygiene, Quality Assurance and more. Taking place on 9th and 10th May in London, UK. With a key focus on expanding your community and exploring the latest developments in the industry at this two-day event, including key regulatory updates, and leading case studies from leading
FDA Keynote Speaker at SMi's 5th Annual Pharmaceutical Microbiology East Coast C …
SMi Group Reports: Keynote FDA speaker Dr. John Arigo, to present at the 4th Annual Pharmaceutical Microbiology East Coast, taking place in just 3 weeks' time on April 27th and 28th, 2022. With just three weeks remaining until the highly anticipated conference, SMi Group are delighted to announce a key FDA Speaker joining the 5th Annual Pharmaceutical Microbiology East Coast Conference. This event will take place on April 27th and
Group Captain (ret'd) Robert Daisley invites you to attend Air Mission Planning …
SMi Group reports: Chairman Group Captain (ret'd) Robert Daisley of the Air Mission Planning and Support Conference cordially invites experts to join the conference in London, UK in one week. With only one week remaining, SMi Group is delighted to publish an invitation letter for SMi's 13th Annual Air Mission Planning & Support Conference, taking place on the 6th and 7th April 2022 in London, UK from the conference chairman. The

All 5 Releases